No influence of haemodialysis on interferon production in the QuantiFERON-TB Gold-In-Tube test

Journal of Nephrology

Volumn 24, Issue 5, 2011, Pages 625-630

  Hoogewerf, Martine ^a   Boland, Greet J ^a   Hoepelman, Andy I M ^a   Boer, Walther H ^a   Mudrikova, Tania ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Haemodialysis; Interferon gamma release assay; QuantiFERON TB Gold test

Indexed keywords

GAMMA INTERFERON;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; HEMODIALYSIS; HUMAN; IMMUNOASSAY; INTERFERON PRODUCTION; KIDNEY FAILURE; LATENT TUBERCULOSIS; MALE; QUANTIFERON TB GOLD IN TUBE TEST;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; ENZYME-LINKED IMMUNOSPOT ASSAY; FEMALE; HUMANS; INTERFERON-GAMMA; KIDNEY FAILURE, CHRONIC; LATENT TUBERCULOSIS; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; NETHERLANDS; PREDICTIVE VALUE OF TESTS; RENAL DIALYSIS; T-LYMPHOCYTES; TIME FACTORS;

EID: 80052647313     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: 10.5301/JN.2011.6325     Document Type: Article

References (21)

1. Descamps-Latscha B, Jungers P, Witko-Sarsat V. Immune system dysregulation in uremia: role of oxidative stress. Blood Purif. 2002;20:481-484.
2. Simon TA, Paul S, Wartenberg D, Tokars JI. Tuberculosis in hemodialysis patients in New Jersey: a statewide study. Infect Control Hosp Epidemiol. 1999;20:607-609.
3. Triverio PA, Bridevaux PO, Roux-Lombard P, Niksic L. Interferon-gamma release assays versus tuberculin skin testing for detection of latent tuberculosis in chronic haemodialysis patients. Nephrol Dial Transplant. 2009;24:1952-1956.
4. Lee SS, Chou KJ, Su IJ, Chen YS. High prevalence of latent tuberculosis infection in patients in end-stage renal disease on hemodialysis: comparison of QuantiFERONTB GOLD, ELISPOT, and tuberculin skin test. Infection. 2009;37:96-102.
5. Shankar MS, Aravindan AN, Sohal PM, Kohli HS. The prevalence of tuberculin sensitivity and anergy in chronic renal failure in an endemic area: tuberculin test and the risk of post-transplant tuberculosis. Nephrol Dial Transplant. 2005;20:2720-2724.
6. Smirnoff M, Patt C, Seckler B, Adler JJ. Tuberculin and anergy skin testing of patients receiving long-term hemodialysis. Chest. 1998;113:25-27.
7. Richeldi L. An update on the diagnosis of tuberculosis infection. Am J Respir Crit Care Med. 2006;174:736-742.
8. Menzies D, Pai M, Comstock G. Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann Intern Med. 2007;146:340-354.
9. Richeldi L, Losi M, D'Amico R. Performance of tests for latent tuberculosis in different groups of immunocompromised patients. Chest. 2009;136(1):198-204.
10. Kobashi Y, Sugiu T, Shimizu H, Ohue Y. Clinical evaluation of the T-SPOT. TB test for patients with indeterminate results on the QuantiFERON TB-2G test. Intern Med. 2009;48:137-142.
11. Kobashi Y, Sugiu T, Mouri K, Obase Y. Indeterminate results of QuantiFERON TB-2G test performed in routine clinical practice. Eur Respir J. 2009;33:812-815.
12. Hoffmann M, Tsinalis D, Vernazza P, Fierz W, Binet I. Assessment of an Interferon-gamma release assay for the diagnosis of latent tuberculosis infection in haemodialysis patients. Swiss Med Wkly. 2010;140:286-292.
13. Chung WK, Zheng ZL, Sung JY, et al. Validity of interferon-gamma-release assays for the diagnosis of latent tuberculosis in haemodialysis patients. Clin Microbiol Infect. 2010;16:960-965.
14. Inoue T, Nakamura T, Katsuma A, et al. The value of QuantiFERON TB-Gold in the diagnosis of tuberculosis among dialysis patients. Nephrol Dial Transplant. 2009;24:2252-2257.
15. Pai M, Joshi R, Dogra S, Mendiratta DK, Narang P, Dheda K et al. Persistently elevated T cell interferon-gamma responses after treatment for latent tuberculosis infection among health care workers in India: a preliminary report. J Occup Med Toxicol. 2006;1:7:1-7.
16. Dewan PK, Grinsdale J, Liska S, Wong E, Fallstad R, Kawamura LM. Feasibility, acceptability, and cost of tuberculosis testing by whole-blood interferon-gamma assay. BMC Infect Dis. 2006;6:47.
17. Mehta SR, MacGruder C, Looney D, Johns S, Smith DM. Differences in tuberculin reactivity as determined in a veterans administration employee health screening program. Clin Vaccine Immunol. 2009;16:541-543.
18. Ferrara G, Losi M, Meacci M, Meccugni B. Routine hospital use of a new commercial whole blood interferon-gamma assay for the diagnosis of tuberculosis infection. Am J Respir Crit Care Med. 2005;172:631-635.
19. Hursitoglu M, Cikrikcioglu MA, Tukek T, Beycan I. Acute effect of low-flux hemodialysis process on the results of the interferon-gamma-based QuantiFERON-TB Gold In-Tube test in end-stage renal disease patients. Transpl Infect Dis. 2009;11:28-32.
20. Martín-Malo A, Carracedo J, Ramírez R, Rodriguez-Benot A. Effect of uremia and dialysis modality on mononuclear cell apoptosis. J Am Soc Nephrol. 2000;11:936-942.
21. Lonnemann G, Novick D, Rubinstein M, Passlick-Deetjen J. A switch to high-flux helixone membranes reverses suppressed interferon-gamma production in patients on low-flux dialysis. Blood Purif. 2003;21:225-231.